In this podcast, Finnegan attorneys Mark Feldstein, Cora Holt, and Tom Irving discuss the impacts of the recent Federal Circuit cases GSK v. Teva and Amarin v. Hikma.
A closed captioning version is available here.
United States Court of Appeals for the Federal Circuit (CAFC), drugs, Food and Drug Administration (FDA)
Conference
4th Annual Passport to Proficiency on the Essentials of Hatch-Waxman and BPCIA
October 8-24, 2024
Virtual
Hybrid Conference
2024 Patent Law Institute: Critical Issues & Best Practices
September 30 - October 1, 2024
New York
Seminar
Intellectual Property in the Age of AI: What Do You Own and How Do You Balance Risks?
September 25, 2024
Boston
At the PTAB Blog
IPR and PGR Statistics for Final Written Decisions Issued in June 2024
August 22, 2024
Federal Circuit IP Blog
August 16, 2024
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.